The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle
- PMID: 1501299
- PMCID: PMC289135
- DOI: 10.1128/JVI.66.9.5667-5670.1992
The C terminus of human immunodeficiency virus type 1 matrix protein is involved in early steps of the virus life cycle
Abstract
Deletion mutations at the C terminus of the matrix (MA) protein of human immunodeficiency virus type 1 (HIV-1) were generated by site-directed mutagenesis. The resultant mutant viruses had a severe defect in virus infectivity. This defect did not involve late steps of the virus life cycle, as the synthesis and processing of the Gag polyprotein and the assembly and release of mutant virions were not greatly affected. The incorporation of viral proteins and the viral RNA genome was similar for mutant and wild-type virions. In contrast, the early steps of the virus life cycle were severely affected, as the synthesis of viral DNA postinfection was dramatically reduced in mutant-virus-infected cells. One stretch of amino acids that was deleted in one of the mutants has significant homology with a region in VP1 of the picornavirus family. This region of VP1 is presumably involved in poliovirus penetration into cells. These results suggest that in addition to its functional role in virus assembly, the MA protein of HIV-1, and possibly of other retroviruses, plays an important role in virus entry.
Similar articles
-
The matrix protein of human immunodeficiency virus type 1 is required for incorporation of viral envelope protein into mature virions.J Virol. 1992 Aug;66(8):4966-71. doi: 10.1128/JVI.66.8.4966-4971.1992. J Virol. 1992. PMID: 1629961 Free PMC article.
-
Role of matrix in an early postentry step in the human immunodeficiency virus type 1 life cycle.J Virol. 1998 May;72(5):4116-26. doi: 10.1128/JVI.72.5.4116-4126.1998. J Virol. 1998. PMID: 9557701 Free PMC article.
-
Mutations in the matrix protein of human immunodeficiency virus type 1 inhibit surface expression and virion incorporation of viral envelope glycoproteins in CD4+ T lymphocytes.J Virol. 1997 Feb;71(2):1443-52. doi: 10.1128/JVI.71.2.1443-1452.1997. J Virol. 1997. PMID: 8995670 Free PMC article.
-
HIV-1 replication.Somat Cell Mol Genet. 2001 Nov;26(1-6):13-33. doi: 10.1023/a:1021070512287. Somat Cell Mol Genet. 2001. PMID: 12465460 Review.
-
Mutational analysis of HIV-1 gag proteins (review).Int J Mol Med. 2000 Sep;6(3):265-9. doi: 10.3892/ijmm.6.3.265. Int J Mol Med. 2000. PMID: 10934287 Review.
Cited by
-
Phenotypic characterization of insertion mutants of the human immunodeficiency virus type 1 Gag precursor expressed in recombinant baculovirus-infected cells.J Virol. 1994 Jan;68(1):111-22. doi: 10.1128/JVI.68.1.111-122.1994. J Virol. 1994. PMID: 8254720 Free PMC article.
-
Association of VH4-59 Antibody Variable Gene Usage with Recognition of an Immunodominant Epitope on the HIV-1 Gag Protein.PLoS One. 2015 Jul 30;10(7):e0133509. doi: 10.1371/journal.pone.0133509. eCollection 2015. PLoS One. 2015. PMID: 26226263 Free PMC article.
-
Structural analysis of human immunodeficiency virus type 1 Gag protein interactions, using cysteine-specific reagents.J Virol. 1996 Aug;70(8):5106-14. doi: 10.1128/JVI.70.8.5106-5114.1996. J Virol. 1996. PMID: 8764018 Free PMC article.
-
Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmission.J Virol. 1999 Mar;73(3):1860-7. doi: 10.1128/JVI.73.3.1860-1867.1999. J Virol. 1999. PMID: 9971764 Free PMC article.
-
Translation elongation factor 1-alpha interacts specifically with the human immunodeficiency virus type 1 Gag polyprotein.J Virol. 1999 Jul;73(7):5388-401. doi: 10.1128/JVI.73.7.5388-5401.1999. J Virol. 1999. PMID: 10364286 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources